A Target Occupancy Study With Ritlecitinib.
Clinical trial NCT05128058 · COMPLETED
Trial details
- NCT number
- NCT05128058
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2022-01-14
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.